Most of the 7investing team joins the show to share their process for adding stocks to their personal holdings. We’ll talk about what it takes to get on our radar and when we actually make the decision to buy (as well as how we buy). We’ll also be talking investing mistakes we wish we could have back and be taking your questions live at a special 12:30 p.m. start time. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to o...
Jul 16, 2021•52 min•Season 2Ep. 89
Special purpose acquisition companies -- commonly known as "SPACs" -- are becoming increasingly popular in recent years as a way for companies to reach the public markets. While there were only 59 companies that chose to do a "SPAC IPO" in 2019, more than 360 have already taken place thus far in 2021. The total value of funds raised from those SPAC IPOs this year has exceeded $112 billion, and there are reportedly more than 300 more SPACs that have raised funds and are looking for a target. But ...
Jul 15, 2021•56 min•Season 2Ep. 88
The pandemic has led to a shortage of workers as some people have opted to not come back to the workforce for reasons ranging from childcare issues (and schools not being fully open) to others opting to keep collecting unemployment. That has forced many large companies offer wages that reach or even exceed $15 an hour. It could also make those same businesses consider they want to spend the money needed to automate their workforce. Anirban Mahanti joins Dan Kline to break down the labor market a...
Jul 14, 2021•46 min•Season 2Ep. 87
The restaurant industry suffered as much as any other during the pandemic. Dining rooms closed, companies had to pivot to takeout and curbside pickup. Even when dining rooms could open, they opened with limited capacities in many places. Despite that, consumers were actually fairly happy with the industry, according to results from the most recent American Customer Satisfaction Index (ACSI). David VanAmburg, Managing Director of the ACSI joined the 7investing Podcast to explain why consumers wer...
Jul 13, 2021•32 min•Season 2Ep. 86
“Black Widow” had a great weekend at the box office, but that’s not the full story. Walt Disney also took in big bucks through people paying a premium to watch the movie through the Disney+ streaming service. Is that the new normal or an anomaly? We’ll also discuss Virgin Galactic’s successful space flight and whether the FDA will admit it made a mistake in approving a controversial Alzheimer's drug.
Jul 12, 2021•47 min•Season 2Ep. 85
The facilitator of online retail has made a deal with the internet retail giant to make faster back-end services available to its customers. This is clearly an attempt by BigC to offer services that rival those offered by Shopify. The question remains -- and it’s a really big question -- is will BigCommerce’s customers want Amazon to have access to their data? The answer has been a resounding “no” in other cases where Amazon tried to offer direct merchant services, but it could be different this...
Jul 09, 2021•58 min•Season 2Ep. 84
Special purpose acquisition companies -- commonly known as "SPACs" -- are becoming increasingly popular in recent years as a way for companies to reach the public markets. While there were only 59 companies that chose to do a "SPAC IPO" in 2019, more than 360 have already taken place thus far in 2021. The total value of funds raised from those SPAC IPOs this year has exceeded $112 billion, and there are reportedly more than 300 more SPACs that have raised funds and are looking for a target. But ...
Jul 08, 2021•29 min•Season 2Ep. 83
The Chinese government has shut down new registrations for Didi, a ride-sharing app that just had an IPO on the New York Stock Exchange. This was the biggest IPO since Alibaba in 2014 and the government’s move has investors questioning whether more regulation will be coming for other publicly-traded stocks that are based in China. Maxx Chatsko and Steve Symington join Dan Kline on the July 7 edition of “7investing Now” to figure out what this means for the long-term prospects of investing in Chi...
Jul 07, 2021•53 min•Season 2Ep. 82
It's often said that biotech stocks trade on binary events, such as public disclosures of clinical trial data or regulatory approvals. That's true to some extent, but there's a bit more nuance for investors to consider. Pre-commercial drug developers don't have recurring revenue, earnings, or operating cash flow to interrogate when determining fair value, which forces Wall Street analysts and savvy investors to lean on other valuation tools. Net present value (NPV) and risk-adjusted net present ...
Jul 06, 2021•27 min•Season 2Ep. 81
It’s 4th of July weekend and we’re celebrating with a special edition of “7investing Now.” On this episode Anirban Mahanti joins Dan Kline to break down how anyone can take control of their finances and begin their investing journey. They’ll discuss what you have to do before you can start investing and then they’ll layout the steps you need to take to build long-term wealth. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock mark...
Jul 02, 2021•34 min•Season 2Ep. 80
Note: This is Part 2 of our two-part 7investing interview with Muji. If there's one thing you can count on with technology, it's that it can completely change the way we do things. Music that used to be played on vinyl records is now being listened to through Bluetooth earbuds as digital mp3. Film reels in movie theaters were replaced by VCRs, which then got replaced by Smart TV streaming. Stick-shift cars eventually became fully-autonomous, while libraries evolved into digital assistants in our...
Jul 01, 2021•36 min•Season 2Ep. 79
We’re headed into 4th of July weekend and we’re doing the first of two special shows focusing on achieving financial freedom. But, breaking news has caused us to change plans a little bit and we’re going to kick off the show by Walmart’s blockbuster plan to sell insulin for about half what it currently goes for. Dana Abramovirtz and Maxx Chatsko join “7investing Now” to discuss whether this could be a major market disruptor and force drug companies to make changes,. Then, we’re going to talk abo...
Jul 01, 2021•42 min•Season 2Ep. 78
If there's one thing you can count on with technology, it's that it can completely change the way we do things. Music that used to be played on vinyl records is now being listened to through Bluetooth earbuds as digital mp3. Film reels in movie theaters were replaced by VCRs, which then got replaced by Smart TV streaming. Stick-shift cars eventually became fully-autonomous, while libraries evolved into digital assistants in our living room. There's no industry that's immune to technological inno...
Jun 29, 2021•32 min•Season 2Ep. 77
We’re back baby! But normal might not look the same going forward. It’s possible that the pandemic has changed certain behaviours. That will be good for some industries, bad for others, and just generally change the rules for many more. Maxx Chatsko joins Dan Kline to break down how this might work for investors. We’ll also check in on Intellia Therapeutics and take your questions. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stoc...
Jun 28, 2021•45 min•Season 2Ep. 76
A lot of money has been made by tracking our identities on the internet. Social media sites follow our behavior and use those breadcrumbs to serve us ads even though we never opted in to letting that happen. That’s in the process off changing as we move to an opt-in world where companies have to explicitly ask for permission and Simon Erickson joins 7investing Now to explain what this means for investors. Plus, Anirban Mahanti sat down with Dan Kline to discuss whether there’s a real chance Comc...
Jun 25, 2021•56 min•Season 2Ep. 75
Improving health care by making it more convenient The journey a patient makes in the health care system can be a long one - from getting an appointment, to waiting to see the physician, to finally getting a prescription for treatment. Any roadblock on that journey, often something simple such as picking up a prescription, can have devastating consequences. Value-based care is all about focusing on the patient - providing them the best quality care for the least amount of cost. It is also about ...
Jun 24, 2021•23 min•Season 2Ep. 74
You can’t invest if you don’t have excess money in your budget. A lot of people make little financial mistakes that collectively hurt their ability to buy stocks and make long-term financial moves. Maxx Chatsko joins Dan Kline to talk about some of the financial drains that can be avoided (and a few that maybe can’t). We’ll also look at the first in vivo clinical results for CRISPR gene editing. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ide...
Jun 23, 2021•49 min•Season 2Ep. 73
"10-Baggers" are prime examples of the amazing power of compounding in investing. The term was originally coined by legendary investor Peter Lynch in his book <em>One Up on Wall Street.</em> It refers to a company that goes on to return 10 times your initial investment, turning $1,000 into $10,000 or $100,000 into $1 million. Lynch went on to become one of the greatest money managers of all time. He ran Fidelity's Magellan Fund for 13 years and achieved an incredible compound average...
Jun 22, 2021•42 min•Season 2Ep. 72
The pandemic changed a lot about how many white-collar workers work. Many people who used to go to an office every day stopped doing that. Going forward, not everyone will be heading back to a traditional five-day-a-week in-office work schedule. That’s going to have ramifications across the economy. Steve Symington joins Dan Kline on “7investing Now” live at noon to discuss what this means for investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7...
Jun 21, 2021•57 min•Season 2Ep. 71
We’re checking in on the progress of the space race and looking at Google’s partnership with a hospital chain to disrupt healthcare. In addition, we’ll take a look at just how far momentum can take drug companies and examine some of the legislative attempts to regulate big tech. Then, we’ll close the show by talking about the investing advice we wish we had known sooner. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to...
Jun 18, 2021•55 min•Season 2Ep. 71
America's health care system is a complex beast. It's costing us $4 trillion per year -- roughly $11,000 for every man, woman, and child in the country -- and that's nearly double the per capita spend of other developed nations. Even with the premium price tag, our health outcomes are still lagging many of those other countries. However, there is still cause for optimism. We've diagnoses several of our health care's symptoms, and higher-level changes are taking place to provide some much-needed ...
Jun 17, 2021•13 min•Season 2Ep. 70
The pandemic has shown that America has a lot of problems with its healthcare system. There’s a political component to that, but there’s also a lot of private efforts underway to disrupt the current system. Maxx Chatsko and Dana Abramowitz join Dan Kline for 7investing Now to look at what’s happening in this space and what it means for investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just...
Jun 17, 2021•51 min•Season 2Ep. 69
In this conversation, 7investing Lead Advisor Matthew Cochrane sits down with Ryan Krueger, the co-founder and CEO of Freedom Day Solutions, a family-owned and operated financial advisory firm located in Houston. Krueger believes that there are countless and confusing ways to plan for retirement. Even at their best, a withdrawal rate based on a projected return is a guess, sometimes based on just a little more than hopes and prayers. Krueger thinks there's a better way to plan for retirement, bu...
Jun 15, 2021•49 min•Season 2Ep. 68
Bipartisan legislation has been proposed in the House of Representatives that would impose significant regulation on large technology companies. The multiple bills, if passed, would change the rules for companies including Alphabet, Facebook, and Apple. This could result in some of these companies being broken up or having to sell some parts of their businesses. Steve Symington joins Dan Kline on “7investing Now” to break down what this means for investors. Welcome to 7investing. We are here to ...
Jun 14, 2021•46 min•Season 2Ep. 67
The advertising industry is continuously evolving. From billboards to newspapers, from radios to television, and from desktops to Smartphones, technology has been changing the way that companies appeal to prospective consumers for decades. And efficiency has always been at the very heart of advertising. Businesses are looking to grow their top line at the most optimal return on investment possible. The internet introduced new ways for companies to maximize that ROI of their ad spend. Search engi...
Jun 10, 2021•27 min•Season 2Ep. 65
It's been a long and winding road for synthetic biology. The first wave of publicly-traded companies emerged in the late 2000s and early 2010s. Many were founded on the promise of engineering microbes to produce renewable fuels, which could ease supply constraints and price volatility. It's easy to forget now, but before fracking came along the world was legitimately worried about Peak Oil. Unfortunately, all efforts to manufacture cost-competitive microbial fuels crashed and burned. The technic...
Jun 08, 2021•1 hr 16 min•Season 2Ep. 63
Every 7investing lead advisor has a different method for evaluating companies. Some use a more technical style while others have a mixed approach that also involves personal experience. We all value different metrics in different ways and on this episode of “7investing Now,” Dan Kline and Maxx Chatsko will share how they pick the companies they invest in personally and how they find their monthly pick for 7investing members. Welcome to 7investing. We are here to empower you to invest in your fut...
Jun 07, 2021•47 min•Season 2Ep. 62
The pandemic has changed some Americans’ minds about where they want to live. That has sent more people from big cities to smaller towns. Will this mean a resurgence for small-town Americans -- and what might that mean for investors. Dan Kine and Matt Cochrane will cover what’s happening and give you three companies poised to benefit from this population shift. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subsc...
Jun 04, 2021•49 min•Season 2Ep. 61
Anirban Mahanti sat down with Mayur Thaker, a Senior Relationship Manager at Zacks Investment Research, to chat about hypergrowth investing. This conversation is all about investing in rapidly growing companies with huge addressable markets. As investors, we need a framework to study these options: how do we evaluate the investment opportunities in businesses at the bleeding edge of their respective domains? So, grab a coffee (or any other favorite drink!), and let's learn about hypergrowth inve...
Jun 03, 2021•1 hr 32 min•Season 2Ep. 60
Our very first 7investing principle is that investing is personal. We believe no one knows your investing style, risk tolerance, or future goals better than you do. As such, the "right" way to invest and the "best" stocks in the market will necessarily be different for each individual. But many people still feel like they don't understand the stock market or that investing is a game that's rigged against them. And while financial literacy is certainly improving every year, there's still a lot of...
Jun 01, 2021•26 min•Season 2Ep. 59
